Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Tuba Nur Gide"'
Autor:
Hansol Lee, Camelia Quek, Ines Silva, Annie Tasker, Marcel Batten, Helen Rizos, Su Yin Lim, Tuba Nur Gide, Ping Shang, Grace H. Attrill, Jason Madore, Jarem Edwards, Matteo S. Carlino, Alexander Guminski, Robyn P.M. Saw, John F. Thompson, Peter M. Ferguson, Umaimainthan Palendira, Alexander M. Menzies, Georgina V. Long, Richard A. Scolyer, James S. Wilmott
Publikováno v:
OncoImmunology, Vol 8, Iss 2 (2019)
Purpose: Anti-PD-1 therapy has revolutionized the treatment and improved the survival of stage IV melanoma patients. However, almost half of the patients fail to respond due to immune evasive mechanism. A known mechanism is the downregulation of majo
Externí odkaz:
https://doaj.org/article/99ab392d7e6b45fbb50cf5649f13f283
Autor:
Hansol Lee, Angela L. Ferguson, Camelia Quek, Ismael A. Vergara, Ines Pires daSilva, Ruth Allen, Tuba Nur Gide, Jordan W. Conway, Lambros T. Koufariotis, Nicholas K. Hayward, Nicola Waddell, Matteo S. Carlino, Alexander M. Menzies, Robyn P.M. Saw, Elena Shklovskaya, Helen Rizos, Serigne Lo, Richard A. Scolyer, Georgina V. Long, Umaimainthan Palendira, James S. Wilmott
Publikováno v:
Clinical Cancer Research. :OF1-OF12
Purpose: This study characterizes intratumoral macrophage populations within baseline melanoma biopsies from patients with advanced melanoma who received either anti-PD-1 monotherapy or a combination with anti-CTLA-4. Particularly, FcγRIIIa (CD16)-e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d784ce8b1109474c90649f699faeba2
https://doi.org/10.1158/1078-0432.ccr-22-2657
https://doi.org/10.1158/1078-0432.ccr-22-2657
Autor:
James S. Wilmott, Umaimainthan Palendira, Georgina V. Long, Richard A. Scolyer, Serigne Lo, Helen Rizos, Elena Shklovskaya, Robyn P.M. Saw, Alexander M. Menzies, Matteo S. Carlino, Nicola Waddell, Nicholas K. Hayward, Lambros T. Koufariotis, Jordan W. Conway, Tuba Nur Gide, Ruth Allen, Ines Pires daSilva, Ismael A. Vergara, Camelia Quek, Angela L. Ferguson, Hansol Lee
C1Q and PD-1 expression on CD16+ macrophages in on treatment biopsies of melanoma patients treated with PD-1 or PD-1+CTLA-4 ICB. Dynamics between pretreatment and early-during treatment biopsies on (a) CD16+ macrophages as a proportion of all macroph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14612cae31cb766578780e949a0d035e
https://doi.org/10.1158/1078-0432.22490758.v1
https://doi.org/10.1158/1078-0432.22490758.v1
Autor:
James S. Wilmott, Umaimainthan Palendira, Georgina V. Long, Richard A. Scolyer, Serigne Lo, Helen Rizos, Elena Shklovskaya, Robyn P.M. Saw, Alexander M. Menzies, Matteo S. Carlino, Nicola Waddell, Nicholas K. Hayward, Lambros T. Koufariotis, Jordan W. Conway, Tuba Nur Gide, Ruth Allen, Ines Pires daSilva, Ismael A. Vergara, Camelia Quek, Angela L. Ferguson, Hansol Lee
Differential expression analysis gene list of FACS sorted CD16+ compared to CD16- macrophages from human melanoma dissociates.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6232323a8928f6748dc05f4042e2cbe0
https://doi.org/10.1158/1078-0432.22490749
https://doi.org/10.1158/1078-0432.22490749
Autor:
James S. Wilmott, Umaimainthan Palendira, Georgina V. Long, Richard A. Scolyer, Serigne Lo, Helen Rizos, Elena Shklovskaya, Robyn P.M. Saw, Alexander M. Menzies, Matteo S. Carlino, Nicola Waddell, Nicholas K. Hayward, Lambros T. Koufariotis, Jordan W. Conway, Tuba Nur Gide, Ruth Allen, Ines Pires daSilva, Ismael A. Vergara, Camelia Quek, Angela L. Ferguson, Hansol Lee
Purpose:This study characterizes intratumoral macrophage populations within baseline melanoma biopsies from patients with advanced melanoma who received either anti-PD-1 monotherapy or a combination with anti-CTLA-4. Particularly, FcγRIIIa (CD16)-ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c6f2199d79af940132b22b50fc8fbba
https://doi.org/10.1158/1078-0432.c.6533212.v1
https://doi.org/10.1158/1078-0432.c.6533212.v1
Autor:
Umaimainthan Palendira, Richard A. Scolyer, Georgina V. Long, Alexander M. Menzies, John F. Thompson, Robyn P.M. Saw, Warwick J. Britton, Wolfgang Weninger, Thomas Gebhardt, Peter Hersey, Rehana Hewavisenti, Jinbiao Chen, Angela Ferguson, Annie Tasker, Camelia Quek, Tuba Nur Gide, Jason Madore, James S. Wilmott, Jarem Edwards
Purpose: Therapeutic blockade of immune checkpoints has revolutionized cancer treatment. Durable responses, however, occur in less than half of those treated, and efforts to improve treatment efficacy are confounded by a lack of understanding of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbde0c7bbd6a81d0078a02fdb2f872d2
https://doi.org/10.1158/1078-0432.c.6525660.v1
https://doi.org/10.1158/1078-0432.c.6525660.v1
Autor:
Umaimainthan Palendira, Richard A. Scolyer, Georgina V. Long, Alexander M. Menzies, John F. Thompson, Robyn P.M. Saw, Warwick J. Britton, Wolfgang Weninger, Thomas Gebhardt, Peter Hersey, Rehana Hewavisenti, Jinbiao Chen, Angela Ferguson, Annie Tasker, Camelia Quek, Tuba Nur Gide, Jason Madore, James S. Wilmott, Jarem Edwards
Supplementary data on flow cytometry analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b62fb5d05b20a5b5bb90e37003501ec
https://doi.org/10.1158/1078-0432.22464264
https://doi.org/10.1158/1078-0432.22464264
Autor:
Umaimainthan Palendira, Richard A. Scolyer, Georgina V. Long, Alexander M. Menzies, John F. Thompson, Robyn P.M. Saw, Warwick J. Britton, Wolfgang Weninger, Thomas Gebhardt, Peter Hersey, Rehana Hewavisenti, Jinbiao Chen, Angela Ferguson, Annie Tasker, Camelia Quek, Tuba Nur Gide, Jason Madore, James S. Wilmott, Jarem Edwards
Supplementary table with clinical data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ada474d5378eaa4cc39c032c5093e6a
https://doi.org/10.1158/1078-0432.22464258
https://doi.org/10.1158/1078-0432.22464258
Autor:
Serigne N. Lo, Tuba Nur Gide, Maria Gonzalez, Ines Silva, Alexander M. Menzies, Matteo S. Carlino, Richard A. Scolyer, Stephane Heritier, James S. Wilmott, Georgina V. Long
Publikováno v:
Journal of Clinical Oncology. 40:TPS9599-TPS9599
TPS9599 Background: Anti-PD1-based immunotherapies have been approved for many cancer types and are now a standard therapy for advanced melanoma. Despite this, ̃50% of advanced melanoma patients (pts) fail to respond or eventually progress after res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8feadb65f86893eb3e03d9f314dc5c5f
https://doi.org/10.1200/jco.2022.40.16_suppl.tps9599
https://doi.org/10.1200/jco.2022.40.16_suppl.tps9599
Autor:
Jarem, Edwards, James S, Wilmott, Jason, Madore, Tuba Nur, Gide, Camelia, Quek, Annie, Tasker, Angela, Ferguson, Jinbiao, Chen, Rehana, Hewavisenti, Peter, Hersey, Thomas, Gebhardt, Wolfgang, Weninger, Warwick J, Britton, Robyn P M, Saw, John F, Thompson, Alexander M, Menzies, Georgina V, Long, Richard A, Scolyer, Umaimainthan, Palendira
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 24(13)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::140fe92c63d5e376bd086faabd2fb832
https://pubmed.ncbi.nlm.nih.gov/29599411
https://pubmed.ncbi.nlm.nih.gov/29599411